Literature DB >> 18712672

Loss of a reporter gene for green fluorescent protein during tumor progression suggests the recruitment of host cells in rats with experimentally induced colon cancer.

D C García-Olmo1, J Samos, M G Picazo, G Fernández-Miguel, I Toboso, D García-Olmo.   

Abstract

The interactions between a host's normal cells and tumor cells appear to be of significant importance during the development of tumors. In the present study, we examined this issue using a cancer model in vivo in which tumor cells were tagged with a reporter gene for green fluorescent protein (GFP). We used a model of colon cancer in immunocompetent rats, which were given a subcutaneous injection of tumor cells that had been transfected with a gene for GFP. We found that the number of fluorescent cells decreased with the progression of the primary tumors and that lymph node and lung metastases were never macroscopically fluorescent. No GFP-encoding sequences were detected by PCR in many of the long-term primary tumors, in most lymph node metastases (86%) and in all lung metastases, whereas the detection of mutated k-ras, which identified such cells as tumor cells, was always positive. To explain these findings, we present a brief review of the literature and postulate that tumor growth did not occur exclusively as a result of the division of the injected cells, but also involved recruitment of host cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18712672     DOI: 10.14670/HH-23.1205

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  2 in total

1.  Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats.

Authors:  Dolores C García-Olmo; María G Picazo; Inmaculada Toboso; Ana I Asensio; Damián García-Olmo
Journal:  Mol Cancer       Date:  2013-02-04       Impact factor: 27.401

Review 2.  Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.

Authors:  Feifei Cheng; Li Su; Cheng Qian
Journal:  Oncotarget       Date:  2016-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.